Copyright
©The Author(s) 2018.
World J Clin Cases. Sep 6, 2018; 6(9): 249-258
Published online Sep 6, 2018. doi: 10.12998/wjcc.v6.i9.249
Published online Sep 6, 2018. doi: 10.12998/wjcc.v6.i9.249
Table 3 Grading of fibrosis and statistical results based on various criteria
| Control (Group 1) | Sorafenib (Group 2) | |||||
| Assessment measure | Grade | n | % | n | % | P |
| Fibrosis score | 0 | 0 | 0 | 4 | 50 | < 0.001 |
| 1 | 0 | 0 | 4 | 50 | ||
| 3 | 8 | 100 | 0 | 0 | ||
| Fibroblast density | 1 | 0 | 0 | 8 | 100 | < 0.001 |
| 3 | 8 | 100 | 0 | 0 | ||
| Inflammatory cell density | 1 | 0 | 0 | 6 | 75 | < 0.001 |
| 2 | 2 | 25 | 2 | 25 | ||
| 3 | 6 | 75 | 0 | 0 | ||
| CD105-stained microvessels | 1 | 0 | 0 | 6 | 75 | < 0.001 |
| 2 | 2 | 25 | 2 | 25 | ||
| 3 | 6 | 75 | 0 | 0 | ||
| Osteopontin-stained microvessels | 1 | 4 | 50 | 7 | 87.5 | 0.355 |
| 2 | 2 | 25 | 1 | 12.5 | ||
| 3 | 2 | 25 | 0 | 0 | ||
- Citation: Tanriverdi O, Erdogan U, Tanik C, Yilmaz I, Gunaldi O, Adilay HU, Arslanhan A, Eseoglu M. Impact of sorafenib on epidural fibrosis: An immunohistochemical study. World J Clin Cases 2018; 6(9): 249-258
- URL: https://www.wjgnet.com/2307-8960/full/v6/i9/249.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i9.249